KA/EN
Register
Medicines reference
Search
Search
Product

Giskan-5

Favourites

Canine distemper virus + Canine parvovirus + Canine coronavirus + Canine adenovirus · Vetbiochim LLC

1 form: solution. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Enter weight; the matching row will be highlighted.
Form Species Weight Dose Frequency Georgia
Solution · Dog up to 5 kg Dog up to 5 kg 1 ml (2 ml)
Best effect is expected early in disease. Do not administer to dogs ill or debilitated with another infectious disease.
 · 1-3 administrations at 12-24-hour intervals		 1-3 administrations at 12-24-hour intervals Georgia Yes, veterinary
In force until 12 Sep 2031
Veterinary (National Food Agency)
In the register: გისკანი
№ 001248
Verified on: 21 Oct 2026
Solution · Dog over 5 kg Dog over 5 kg 2 ml (2 ml)
Best effect is expected early in disease. Do not administer to dogs ill or debilitated with another infectious disease.
 · 1-3 administrations at 12-24-hour intervals		 1-3 administrations at 12-24-hour intervals Georgia Yes, veterinary
In force until 12 Sep 2031
Veterinary (National Food Agency)
In the register: გისკანი
№ 001248
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Giskan-5, Solution

immune serum, 2 ml N10 for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
5.1/10
Weak evidence support
vetman assessment

Giskan-5

immune serum, 2 ml N10 for dogs
Assessed clinical scopeDog · Full dog label: passive prevention and adjunctive treatment of distemper, parvovirus, coronavirus and adenovirus infection with equine immune serum · SC,IM
Care settingVeterinary-directed passive immunisation or adjunct treatment alongside standard intensive supportive care
vetman score 5.1/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 001248 · Verified on 21 Oct 2026

A weak option: equine antiserum with no controlled evidence in dogs. It must never replace vaccination or intensive supportive treatment of parvovirus or distemper.

Regulatory and scientific credibility4.5/10

The exact product is registered in Georgia (001248, valid to 2031) with manufacturer antibody titres, but no EU, UK or US authorisation was documented in the reviewed evidence, public dossier or independent product study exists.

Clinical efficacy4.0/10

Heterologous equine antibodies give short passive protection at best; no controlled canine outcome study supports this product, and parvovirus and distemper care relies on vaccination and intensive supportive treatment.

Safety and tolerability6.0/10

Equine protein can cause hypersensitivity and serum-sickness reactions, especially on repeat courses, and independent safety data are not available.

Clinical practicality6.5/10

One to three SC or IM doses 12-24 hours apart are feasible in clinic or hospital care.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use instead of vaccination or instead of fluid, antiemetic, nutritional and antimicrobial supportive care for parvovirus or distemper.
  • Equine protein can cause anaphylaxis or serum sickness, especially on repeated use; observe after injection and keep emergency treatment ready.
  • Passive antibodies can blunt the response to a vaccine given soon afterwards; plan the vaccination interval accordingly.
  • Do not give to dogs already ill or debilitated with another infectious disease; best effect is expected only early in disease.
  • Handle aseptically and store as a cold-chain biological product.
Assessment sources
  1. Vetbiochim Giskan
  2. Georgia NFA register 20262026
  3. WSAVA vaccination 20242024
  4. AAHA canine vaccination 20222022
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Canine distemper virus128 titre/dose Canine parvovirus128 titre/dose Canine coronavirus64 titre/dose Canine adenovirus32 titre/dose
Formulation Type
Solution
Administration route
subcutaneous, intramuscular
Manufacturer
Vetbiochim LLC · Russia
Manufacturer (register)
Vetbiochim Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1852, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
In force until 12 Sep 2031
Veterinary (National Food Agency)
In the register: გისკანი
№ 001248
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
1 ml (2 ml)
Best effect is expected early in disease. Do not administer to dogs ill or debilitated with another infectious disease.
 Dog up to 5 kg subcutaneous,intramuscular 1-3 administrations at 12-24-hour intervals
Vetbiochim Giskan
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Giskan-5 - current official instruction
Official manufacturer veterinary instruction
2 ml (2 ml)
Best effect is expected early in disease. Do not administer to dogs ill or debilitated with another infectious disease.
 Dog over 5 kg subcutaneous,intramuscular 1-3 administrations at 12-24-hour intervals
Vetbiochim Giskan
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Giskan-5 - current official instruction
Official manufacturer veterinary instruction

Canine distemper virus: No dose supported by a publicly verifiable source yet

Canine parvovirus: No dose supported by a publicly verifiable source yet

Canine coronavirus: No dose supported by a publicly verifiable source yet

Canine adenovirus: No dose supported by a publicly verifiable source yet

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 21 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗